New Year's day before 10 shares of Heng Tai April most popular

This week will be the last week of 2010, and the share IPO market has also been the latest in a rare 10 bursts of new shares. Data show that the first three days of the week, a total of 10 new offerings, including today's 5 gem new shares, Tian Li Environmental protection, Hengtai April, Zhendong Pharmaceutical, new research shares, December 28, the main board of Hainan rubber, and December 29, 4 of the new board shares hang Pan, Linzhou heavy machinery, West pump shares, Hai Li Mei da.　　In the case of funds can not be set, analysts are expected to today's IPO rate or increase, the emphasis is recommended today Hengtai April, Zhendong Pharmaceutical and tomorrow's Hainan rubber, the Wednesday Linzhou heavy machine. The biggest benefit of a new-stock-intensive issue is the broadening of the scope of investor choice, but there are also investors who are at a loss to choose. For today's 5 gem offerings, Nanjing Securities analyst Wen Lijun introduced, the company's operating performance is good, product comprehensive gross profit margin in addition to the new research shares of 36.3%, the other 4 companies are more than 45%, and the new research shares nearly 3-year market composite growth rate of the highest, 71%, the market performance is quite good. "Comprehensive analysis of the company's market competitiveness and growth potential, we believe that the order of their investment value: New research shares, Hengtai April, Zhendong Pharmaceutical, home Treasure, the days of environmental protection." But considering the new research shares circulation only more than 10 million, p/e ratio of up to 150, absolute price is also higher, recommended priority to purchase Hengtai April. "Public information shows that Hengtai April main business for research and development, sales of oil and gas exploration software, the company has covered the domestic three major oil companies under more than 90% oil field units, 2008, 2009 net profit growth of 153.03%, 120.75% respectively." "Company's comprehensive gross profit margin of 68.4%, is the highest in 5 companies, and nearly 3 years of market composite growth rate of more than 45%, in 5 companies ranked third." Comprehensive consideration of the quality of the company and the rate, today's 5 new shares to optimize Hengtai April. "In addition to Hengtai April, Guotai Zhang Jun and Xinda Securities Division Wang also unanimously recommended today's Zhendong pharmaceutical." Zhang Jun Introduction, Zhendong Pharmaceutical leading product is cancer adjuvant treatment drugs, in 2008 the product in the national drug-resistant drugs sales ranked third. Express journalist Liu Fang